Holen Sie sich die Stockscreener-App
27.12
3.07%
-0.86
Vorhandelsmarkt:
27.44
0.32
+1.18%
Atricure Inc Aktie (ATRC) Neueste Nachrichten
Trading Systems Reacting to (ATRC) Volatility - Stock Traders Daily
Do options traders know something about AtriCure stock we don't? - MSN
AtriCure (ATRC) Q1 2026 Earnings Transcript - AOL.com
Do Options Traders Know Something About AtriCure Stock We Don't? - Yahoo Finance
A Look At AtriCure (ATRC) Valuation As BoxX NoAF Trial Acceleration Draws Investor Attention - Yahoo Finance
AtriCure faces market doubts despite revenue growth; share prices fall. Insider optimism hints at potential turnaround, but long-term earnings are the focus. - Moomoo
AtriCure (ATRC) Advances Key Heart Disease Trial 12 Months Ahead of Schedule - Insider Monkey
AtriCure, Inc. Hits 52-Week Low at USD 25.37 Amid Market Struggles - Markets Mojo
AtriCure stock hits 52-week low at 25.51 USD By Investing.com - Investing.com Australia
AtriCure stock hits 52-week low at 25.51 USD - Investing.com
Top 10 Small Cap Stocks With Huge Growth Potential - Insider Monkey
AtriCure Inc. (ATRC) Slips 1.5% as Stock Hovers Near Key Support at $26.29Chart Pattern Alerts - The Legal Advocate
AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference - Yahoo Finance
Insider Sell Alert: Karen Prange Sells 3,000 Shares of AtriCure Inc (ATRC) - GuruFocus
(ATRC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
AtriCure director Karen Prange sells $85,950 in company stock By Investing.com - Investing.com Canada
AtriCure director Karen Prange sells $85,950 in company stock - Investing.com
AtriCure (ATRC) director Prange sells 3,000 shares, keeps 26,373 - Stock Titan
Director Karen Prange granted 6,144 AtriCure (ATRC) shares - Stock Titan
AtriCure (ATRC) director Deborah Telman awarded 6,144 restricted shares - Stock Titan
AtriCure (ATRC) director Maggie Yuen receives 6,144-share restricted stock award - Stock Titan
Director Nachman Shlomo receives 6,144 AtriCure (ATRC) restricted shares - Stock Titan
Director Kristine Johnson receives 6,144-share grant at AtriCure (ATRC) - Stock Titan
AtriCure (ATRC) director Regina Groves receives 6,144-share restricted stock grant - Stock Titan
AtriCure (ATRC) director Sven Wehrwein receives 6,144-share restricted stock grant - Stock Titan
Director at AtriCure (ATRC) receives 6,144-share restricted stock grant - Stock Titan
[144] AtriCure, Inc. SEC Filing - Stock Titan
AtriCure Shareholders Approve Expanded Equity and Governance Plans - TipRanks
AtriCure (ATRC) stockholders back equity plan share increases and director slate - Stock Titan
AtriCure conference: New devices, EnCompass drive 2026 growth outlook - MSN
Insider Sell: Vinayak Doraiswamy Sells 5,000 Shares of AtriCure Inc (ATRC) - GuruFocus
AtriCure (ATRC) Chief Scientific Officer sells 5,000 shares at $28.13 - Stock Titan
AtriCure Inc Annual Shareholders Meeting Transcript - GuruFocus
How AtriCure scaled legal operations with Thomson Reuters - Thomson Reuters Legal Solutions
Loss-Making AtriCure, Inc. (NASDAQ:ATRC) Set To Breakeven - Moomoo
ATRC (NASDAQ: ATRC) Form 144 shows 5,000-share sale and planned award disposals - Stock Titan
Wellington Management holds 3,382,555 ATRC shares (6.79%) — institutional stake - Stock Titan
AtriCure Inc (ATRC) Shares Surge 5.8% -- What GF Score of 79 Tel - GuruFocus
AtriCure stock (US04963C1099): Q1 revenue jumps 14% to $141M amid return to profit - AD HOC NEWS
AtriCure, Inc.Common Stock (NQ: ATRC - FinancialContent
AtriCure (ATRC) Is Down 5.1% After Q1 Return To Profitability And Higher Revenue Guidance – What's Changed - simplywall.st
TradingKey - TradingKey
AtriCure Conference: New Devices, EnCompass Drive 2026 Growth Outlook - sharewise.com
ATRC: Innovation, clinical trials, and new launches drive growth and reinforce market leadership - TradingView
Transcript : AtriCure, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10 - marketscreener.com
5.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):